![]() |
Helicos BioSciencesHelicos BioSciences is a life-science company committed to developing instruments and reagents for the high speed sequencing of single DNA and RNA molecules. High speed sequencing is a breakthrough tool for solving many important and difficult problems in biology and medicine. Helicos BioSciences’ technology will allow cancer researchers to fully and accurately characterize the cancer genome on tens of thousands of tumors, thereby elucidating the full range of molecular alterations which cause cancer, leading to a new era in cancer diagnosis and therapy. Recent NewsHelicos Announces the Sale of a System to the Turku Centre for BiotechnologyHelicos BioSciences Provides Strategic UpdateOntario Institute for Cancer Research Takes Delivery of a Helicos(TM) Genetic Analysis SystemMassachusetts General Hospital Cancer Center Takes Delivery of a Helicos(TM) Genetic Analysis SystemHelicos BioSciences Announces the Sale of a Helicos(TM) Genetic Analysis SystemHelicos BioSciences Announces Publication in Nature MethodsHelicos to Announce Latest Performance and Applications Data at CHI Next Generation Sequencing Conference |
![]() CEORonald LowyContact InfoOne Kendall SquareSuite 7301 Cambridge, Massachusetts 02139 Phone: 617.264.1800 Fax: 617.264.1700 Key LinksWebsiteJobs Info Career OpportunitiesSales Representative (216510-952)Highland Team Bob Higgins
Corey Mulloy
|